Resilient Pharmaceuticals

Resilient Pharmaceuticals
FormerlyLykos Therapeutics; MAPS Public Benefit Corporation; MAPS PBC
Company typePublic benefit corporation
IndustryPharmaceutical; Psychedelic medicine
Founded2014 (2014)
Websitelykospbc.com

Resilient Pharmaceuticals, formerly known as Lykos Therapeutics and before that as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) developing MDMA ("ecstasy") for potential medicinal use. It was founded and is considerably owned by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS PBC was founded in 2014 and was renamed to Lykos Therapeutics in January 2024. Subsequently, the company was renamed again to Resilient Pharmaceuticals in August 2025.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.